stella
beta
Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension — Stella
Home
/
Resistant Hypertension
/
Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension
View on ClinicalTrials.gov
Recruiting
Back to Resistant Hypertension trials
Early Feasibility Study of "HyperQureTM RDN System", Laparoscopic Renal Denervation Therapy, in Patients With Resistant Hypertension
Not a traditional drug trial — this study doesn't follow the standard phase structure.
Trial locations
(5 sites)
United States
University of California Irvine, Orange, California
Stanford Health Care, Stanford, California
University of Florida College of Medicine, Gainesville, Florida
Henry Forth Health, Detroit, Michigan
Mayo Clinic, Rochester, Minnesota